You have 9 free searches left this month | for more free features.

azd2014

Showing 1 - 13 of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Malignancies Trial in Chuo-ku, Kashiwa (AZD2014)

Active, not recruiting
  • Advanced Solid Malignancies
  • AZD2014
  • Chuo-ku, Japan
  • +1 more
Feb 2, 2023

Meningioma Trial in Chicago, Boston (AZD2014)

Active, not recruiting
  • Meningioma
  • AZD2014
  • Chicago, Illinois
  • +2 more
Oct 15, 2022

NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • AZD2014
  • +10 more
  • Avignon, France
  • +36 more
Jul 29, 2022

Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Metastatic Breast Cancer
  • AZD2014
  • +18 more
  • Angers, France
  • +24 more
Mar 8, 2022

Glioblastoma Multiforme Trial in Canada (AZD2014)

Completed
  • Glioblastoma Multiforme
  • AZD2014
  • Calgary, Alberta, Canada
  • +3 more
Apr 7, 2020

Prostate Cancer Trial in Cambridge (AZD2014)

Completed
  • Prostate Cancer
  • AZD2014
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Jul 15, 2019

Stomach Tumors Trial in Seoul (AZD2014)

Terminated
  • Stomach Neoplasms
  • AZD2014
  • Seoul, Korea, Republic of
    Samsung Medical Center
May 17, 2019

Cancer of Stomach Trial in Seoul (AZD2014)

Terminated
  • Cancer of Stomach
  • AZD2014
  • Seoul, Korea, Republic of
    Samsung Medical Center
May 17, 2019

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD5363, paclitaxel, AZD2014)

Terminated
  • Advanced Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical center
May 17, 2019

Estrogen Receptor Positive Breast Cancer Trial in Worldwide (AZD2014, Everolimus, Fulvestrant)

Unknown status
  • Estrogen Receptor Positive Breast Cancer
  • AZD2014
  • +2 more
  • Angers, France
  • +78 more
Feb 24, 2020

Core: Relapsed or Refractory DLBCL, Module 1: Non-GCB DLBCL Trial (AZD2014, Ibrutinib)

Withdrawn
  • Core: Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  • Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
  • (no location specified)
Sep 14, 2016

Advanced Solid Malignancies Trial in Manchester, Sutton (AZD2014)

Completed
  • Advanced Solid Malignancies
  • AZD2014
  • Manchester, United Kingdom
  • +1 more
Jan 13, 2016

Metastatic Clear Cell Renal Carcinoma Trial in United Kingdom (AZD2014, Everolimus)

Terminated
  • Metastatic Clear Cell Renal Carcinoma
  • Bournemouth, United Kingdom
  • +8 more
Jun 23, 2014